271 related articles for article (PubMed ID: 30146412)
21. A zebrafish model of myelodysplastic syndrome produced through tet2 genomic editing.
Gjini E; Mansour MR; Sander JD; Moritz N; Nguyen AT; Kesarsing M; Gans E; He S; Chen S; Ko M; Kuang YY; Yang S; Zhou Y; Rodig S; Zon LI; Joung JK; Rao A; Look AT
Mol Cell Biol; 2015 Mar; 35(5):789-804. PubMed ID: 25512612
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of TET2 deficiency in myelodysplastic syndromes: A meta-analysis.
Lin Y; Lin Z; Cheng K; Fang Z; Li Z; Luo Y; Xu B
Oncotarget; 2017 Jun; 8(26):43295-43305. PubMed ID: 28476038
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of TET2 mutations in myelodysplastic syndromes: A meta-analysis.
Guo Z; Zhang SK; Zou Z; Fan RH; Lyu XD
Leuk Res; 2017 Jul; 58():102-107. PubMed ID: 28521175
[TBL] [Abstract][Full Text] [Related]
24. What is the role of the microenvironment in MDS?
Calvi LM; Li AJ; Becker MW
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101113. PubMed ID: 31779976
[TBL] [Abstract][Full Text] [Related]
25. Distinct roles for TET family proteins in regulating human erythropoiesis.
Yan H; Wang Y; Qu X; Li J; Hale J; Huang Y; An C; Papoin J; Guo X; Chen L; Kang Q; Li W; Schulz VP; Gallagher PG; Hillyer CD; Mohandas N; An X
Blood; 2017 Apr; 129(14):2002-2012. PubMed ID: 28167661
[TBL] [Abstract][Full Text] [Related]
26. TET2 Mutation and High miR-22 Expression as Biomarkers to Predict Clinical Outcome in Myelodysplastic Syndrome Patients Treated with Hypomethylating Therapy.
Yun J; Ji YS; Jang GH; Lim SH; Kim SH; Kim CK; Bae SB; Won JH; Park SK
Curr Issues Mol Biol; 2021 Aug; 43(2):917-931. PubMed ID: 34449560
[TBL] [Abstract][Full Text] [Related]
27. TET2 deficiency leads to stem cell factor-dependent clonal expansion of dysfunctional erythroid progenitors.
Qu X; Zhang S; Wang S; Wang Y; Li W; Huang Y; Zhao H; Wu X; An C; Guo X; Hale J; Li J; Hillyer CD; Mohandas N; Liu J; Yazdanbakhsh K; Vinchi F; Chen L; Kang Q; An X
Blood; 2018 Nov; 132(22):2406-2417. PubMed ID: 30254129
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
Bai J; Yokomizo-Nakano T; Kubota S; Sun Y; Kanai A; Iimori M; Harada H; Iwama A; Sashida G
Oncogene; 2021 Feb; 40(8):1531-1541. PubMed ID: 33452460
[TBL] [Abstract][Full Text] [Related]
29. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice.
Ko M; Bandukwala HS; An J; Lamperti ED; Thompson EC; Hastie R; Tsangaratou A; Rajewsky K; Koralov SB; Rao A
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14566-71. PubMed ID: 21873190
[TBL] [Abstract][Full Text] [Related]
30. MSI2 is required for maintaining activated myelodysplastic syndrome stem cells.
Taggart J; Ho TC; Amin E; Xu H; Barlowe TS; Perez AR; Durham BH; Tivnan P; Okabe R; Chow A; Vu L; Park SM; Prieto C; Famulare C; Patel M; Lengner CJ; Verma A; Roboz G; Guzman M; Klimek VM; Abdel-Wahab O; Leslie C; Nimer SD; Kharas MG
Nat Commun; 2016 Feb; 7():10739. PubMed ID: 26898884
[TBL] [Abstract][Full Text] [Related]
31. Depletion of
Neelamraju Y; Gjini E; Chhangawala S; Fan H; He S; Jing CB; Nguyen AT; Prajapati S; Sheridan C; Houvras Y; Melnick A; Look AT; Garrett-Bakelman FE
Front Hematol; 2023; 2():. PubMed ID: 37937078
[TBL] [Abstract][Full Text] [Related]
32. Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.
Ostrander EL; Kramer AC; Mallaney C; Celik H; Koh WK; Fairchild J; Haussler E; Zhang CRC; Challen GA
Stem Cell Reports; 2020 Apr; 14(4):551-560. PubMed ID: 32220332
[TBL] [Abstract][Full Text] [Related]
33. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Li Z; Cai X; Cai CL; Wang J; Zhang W; Petersen BE; Yang FC; Xu M
Blood; 2011 Oct; 118(17):4509-18. PubMed ID: 21803851
[TBL] [Abstract][Full Text] [Related]
34. Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells.
McClatchy J; Strogantsev R; Wolfe E; Lin HY; Mohammadhosseini M; Davis BA; Eden C; Goldman D; Fleming WH; Conley P; Wu G; Cimmino L; Mohammed H; Agarwal A
Nat Commun; 2023 Dec; 14(1):8102. PubMed ID: 38062031
[TBL] [Abstract][Full Text] [Related]
35. Tet2 restrains inflammatory gene expression in macrophages.
Cull AH; Snetsinger B; Buckstein R; Wells RA; Rauh MJ
Exp Hematol; 2017 Nov; 55():56-70.e13. PubMed ID: 28826859
[TBL] [Abstract][Full Text] [Related]
36. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
[TBL] [Abstract][Full Text] [Related]
37. Role of SIRT1 in hematologic malignancies.
Huang FT; Sun J; Zhang L; He X; Zhu YH; Dong HJ; Wang HY; Zhu L; Zou JY; Huang JW; Li L
J Zhejiang Univ Sci B; 2019 May; 20(5):391-398. PubMed ID: 31090265
[TBL] [Abstract][Full Text] [Related]
38. Mutation in TET2 in myeloid cancers.
Delhommeau F; Dupont S; Della Valle V; James C; Trannoy S; Massé A; Kosmider O; Le Couedic JP; Robert F; Alberdi A; Lécluse Y; Plo I; Dreyfus FJ; Marzac C; Casadevall N; Lacombe C; Romana SP; Dessen P; Soulier J; Viguié F; Fontenay M; Vainchenker W; Bernard OA
N Engl J Med; 2009 May; 360(22):2289-301. PubMed ID: 19474426
[TBL] [Abstract][Full Text] [Related]
39. [TET2 as a gatekeeper for hematologic malignancies].
Muto H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
[TBL] [Abstract][Full Text] [Related]
40.
Tara S; Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Tanaka T; Shinoda D; Koide S; Saraya A; Miyagi S; Manabe I; Matsui H; Koseki H; Bardwell VJ; Iwama A
Blood; 2018 Dec; 132(23):2470-2483. PubMed ID: 30228234
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
